Although it is still waiting for the drug’s approval, pharmaceutical company Merck has struck a deal to manufacture its COVID-19 antiviral pill Molnupiravir here in Canada.
How exactly will such medications help fight the pandemic? Jamie Maraucher explains the advantage they could give patients.